Clinical experiment on quality control comparison of complex treatment plans of the VMAT technique using a diode-based cylindrical phantom (ArcCHECK) and an amorphous silicon-based planar detector (A-Si1000)
Background: With increasing application of Volumetric Modulated Arc Therapy (VMAT) and the complexity of treatment plans, necessity of patient-specific quality assurance procedures is raised. Therefore, this study aimed to perform VMAT plan control using the ArcCHECK® (Sun Nuclear) and the EPID (Ele...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2ca4ae8feca94413a7d61461b107c370 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Background: With increasing application of Volumetric Modulated Arc Therapy (VMAT) and the complexity of treatment plans, necessity of patient-specific quality assurance procedures is raised. Therefore, this study aimed to perform VMAT plan control using the ArcCHECK® (Sun Nuclear) and the EPID (Electronic Portal Imaging Device) A-Si1000 and make a comparison. Methods: The study was carried out at AL KAWTAR Oncology Center (Fez-Meknes/Morocco) with the TrueBeamTM accelerator and EclipseTM Treatment Planning System (TPS). GeoGebra 6.0 and Origin 2019 software were applied to statistical analysis and to reconstruct the dose distribution maps for ArcCHECK® Phantom, respectively. Gamma index test with the 3%/3 and 2%/2 mm criteria applied to compare two pretreatment quality control instrumentation. Results: Although the EPID A-Si1000 and the ArcCHECK® phantom both were capable of performing VMAT plan control, results of gamma index analysis revealed some differences in the quality of the reviewed plans with the two devices. Conclusion: based on the results, a single device to implement patient QA for complex VMAT plans may not be reliable. Therefore, to ensure patient protection against machine or human errors, applying the EPID A-Si1000 and the ArcCHECK® phantom both are proposed to evaluate the quality of complex VMAT plans for different cancer types. |
|---|